Workflow
金达威(002626.SZ):金达威药业与艾贝德共同设立合资公司

Core Viewpoint - The establishment of a joint venture between Jindawei Pharmaceutical and Aibede Life Science Research Institute aims to enhance the absorption efficiency of various health products through advanced nanocrystal production technology [1] Group 1: Joint Venture Details - Jindawei Pharmaceutical has received notification regarding the establishment of a joint venture with Aibede in Hohhot, Inner Mongolia [1] - The joint venture will focus on applying nanocrystal production technology to products such as Coenzyme Q10, Astaxanthin, Curcumin, and Quercetin [1] Group 2: Strategic Implications - The collaboration is expected to significantly improve the absorption speed and efficiency of the related products [1] - The applications of these enhanced products will extend to both human and pet nutritional health [1]